Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Amortization of Debt Issuance Costs

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Amortization of Debt Issuance Costs

Citius Pharmaceuticals, Inc. (CTXR) reported Amortization of Debt Issuance Costs of $179.49 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-14

  • Citius Pharmaceuticals, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $179.49K.
  • Citius Pharmaceuticals, Inc. amortization of debt issuance costs for fiscal 2014 was $14.00K.
Period endAmortization of Debt Issuance Costs 3 monthAmortization of Debt Issuance Costs 9 monthAmortization of Debt Issuance Costs 12 month
2026-06-30$179.49K
10-Q · filed 2026-08-14
$179.49K
10-Q · filed 2026-08-14
2014-09-30$14.00K
10-K · filed 2016-12-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36